Pharmacological interactions of anti-microbial agents in odontology

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 3, 2009, Pages

  Gómez Moreno, Gerardo ^a   Guardia, Javier ^a   Cutando, Antonio ^a   Calvo Guirado, José Luis ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Anti fungals; Antibiotics; Ciprofloxacin; Clarithromycin; CYP1A2; CYP3A4; Erythromycin; Itraconazol; Ketoconazol; Metronidazol; Odontology

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ATORVASTATIN; AZITHROMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DIGOXIN; ERYTHROMYCIN; FEXOFENADINE; FLUCONAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ITRACONAZOLE; KETOCONAZOLE; LITHIUM; MACROLIDE; METRONIDAZOLE; MEVINOLIN; NEUROLEPTIC AGENT; PRAVASTATIN; SIMVASTATIN; TACROLIMUS; TERFENADINE; THEOPHYLLINE; UNINDEXED DRUG;

ATAXIA; BLEEDING; CONFUSION; DRUG ANTAGONISM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INHIBITION; DRUG POTENTIATION; HEART ARRHYTHMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; INFECTION; KIDNEY FAILURE; MANIA; MYALGIA; NEPHROTOXICITY; PSORIASIS; REVIEW; RHABDOMYOLYSIS; RHEUMATOID ARTHRITIS; SOMNOLENCE; VERTIGO;

ANTI-INFECTIVE AGENTS; DENTISTRY; DRUG INTERACTIONS; HUMANS;

EID: 62549088308     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Stockley IH. Stockley's Drug Interactions. 6th ed. London: Pharmaceutical Press; 2002.
2. Hersh EV, Moore PA. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc. 2004;135:298-311.
3. Gómez Moreno G, Cutando A, Arana C. Visión Odontológica de las Interacciones Farmacológicas. Granada: Grupo Editorial Universitario; 2006.
4. Hersh EV, Moore PA. Adverse drug interactions in dentistry. Periodontol 2000. 2008;46:109-42.
5. Hersh EV. Adverse drug interactions in dental practice: interactions involving antibiotics. Part II of a series. J Am Dent Assoc. 1999;130:236-51.
6. Poveda Roda R, Bagan JV, Sanchis Bielsa JM, Carbonell Pastor E. Antibiotic use in dental practice. A review. Med Oral Patol Oral Cir Bucal. 2007;12:E186-92.
7. Maestre-Vera JR. Treatment options in odontogenic infection. Med Oral Patol Oral Cir Bucal. 2004;9 Suppl:25-31;19-24.
8. Ballow CH, Amsden GW. Azithromycin: the first azalide antibiotic. Ann Pharmacother. 1992;26:1253-61.
9. O'Connor NK, Fris J. Clarithromycin-carbamazepine interaction in a clinical setting. J Am Board Fam Pract. 1994;7:489-92.
10. Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Clin Pharmacol Ther. 2000;68:391-400.
11. Dasgupta A, Okhuysen PC. Pharmacokinetic and other drug interactions in patients with AIDS. Ther Drug Monit. 2001;23:591-605.
12. Sims PJ, Sims KM. Drug interactions important for periodontal therapy. Periodontol 2000. 2007;44:15-28.
13. Recker MW, Kier KL. Potential interaction between clarithromycin and warfarin. Ann Pharmacother. 1997;31:996-8.
14. Honig PK, Cantilena LR. Ketoconazole and fluconazole drug interactions. Arch Intern Med. 1994;154:1038-41.
15. Meechan JG. Polypharmacy and dentistry: 2. Interactions with analgesics and antimicrobials. Dent Update. 2002;29:382-8.
16. Webb MD, Moore PA. Sedation for pediatric dental patients. Dent Clin North Am. 2002;46:803-14.
17. Finch CK, Green CA, Self TH. Fluconazole-carbamazepine interaction. South Med J. 2002;95:1099-100.
18. Moore PA, Gage TW, Hersh EV, Yagiela JA, Haas DA. Adverse drug interactions in dental practice. Professional and educational implications. J Am Dent Assoc. 1999;130:47-54.
19. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 1998;158:1610-6.
20. Wood GD, Deeble T. Warfarin: dangers with antibiotics. Dent Update. 1993;20:350-3.
21. Goa KL, Wagstaff AJ. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs. 1996;51:820-45.
22. Bentué-Ferrer D, Tribut O, Polard E, Allain H. Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists. CNS Drugs. 2003;17:947-63.
23. Tenenbein M. Theophylline toxicity due to drug interaction. J Emerg Med. 1989;7:249-51.
24. Fried R, Fried LW. The effect of Flagyl on xanthine oxidase and alcohol dehydrogenase. Biochem Pharmacol 1966;15:1890-3.
25. Zakeri B, Wright GD. Chemical biology of tetracycline antibiotics. Biochem Cell Biol. 2008;86:124-36.
26. Penning-Van Beest FJ, Koerselman J, Herings RM. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost. 2008;6:284-90.
27. Back DJ, Orme ML. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990;18:472-84.
28. Back DJ, Grimmer SF, Orme ML, Proudlove C, Mann RD, Breckenridge AM. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol. 1988;25:527-32.
29. Bainton R. Interaction between antibiotic therapy and contraceptive medication. Oral Surg Oral Med Oral Pathol. 1986;61:453-5.
30. DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent Clin North Am. 2002;46:653-64.